Cefdinir

Moraxella catarrhalis, Tonsillitis, Tonsillitis + 19 more

Treatment

22 FDA approvals

7 Active Studies for Cefdinir

Treatment for

Moraxella catarrhalis

What is Cefdinir

Cefdinir

The Generic name of this drug

Treatment Summary

Cefdinir, also known as Omnicef, is an antibiotic used to treat a wide range of bacterial infections in the ear, sinus, throat, lungs, and skin. It was approved by the FDA in 1997 and works by blocking the production of beta-lactamase enzymes which can make some bacteria resistant to first-line cephalosporin therapy. Cefdinir is a broad-spectrum antibiotic and is generally very effective and well-tolerated.

Omnicef

is the brand name

image of different drug pills on a surface

Cefdinir Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Omnicef

Cefdinir

1997

175

Approved as Treatment by the FDA

Cefdinir, also known as Omnicef, is approved by the FDA for 22 uses including Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza and Bronchitis .

Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza

Bronchitis

Maxillary Sinusitis

Tonsillitis

Bronchitis, Chronic

Haemophilus parainfluenzae

Uncomplicated skin and skin structure infections caused by streptococcus pyogenes, staphylococcus aureus

Acute exacerbation of chronic bronchitis caused by Haemophilus parainfluenzae

Haemophilus influenzae

Tonsillitis streptococcal

Haemophilus influenzae

Acute maxillary sinusitis caused by Susceptible strains of Streptococcus pneumoniae

Acute maxillary sinusitis caused by H. influenzae

Streptococcal Pharyngitis

acute otitis media caused by S.pneumoniae

Acute Exacerbation of Chronic Bronchitis caused by Streptococcus Pneumoniae

Moraxella catarrhalis

Acute maxillary sinusitis caused by M. catarrhalis

Moraxella catarrhalis

Community acquired pneumonia caused by Susceptible strains of Streptococcus pneumoniae

Bronchitis

Moraxella catarrhalis

Effectiveness

How Cefdinir Affects Patients

Cefdinir is a drug used to treat bacterial infections by stopping the bacteria from creating new cell walls. It has a broad range of effectiveness against both gram-positive and gram-negative bacteria, and is even strong enough to fight against bacteria with beta-lactamase enzymes, which can make them resistant to other cephalosporins.

How Cefdinir works in the body

Cefdinir is an antibiotic with a stronger ability to kill bacteria than penicillin. It works by stopping the bacteria from building their cell walls, which eventually leads to their death. Cefdinir does this by binding to proteins in the bacteria's cell wall and blocking their ability to build the wall. It also has the added benefit of being able to resist enzymes that some bacteria produce to protect themselves from antibiotics. Cefdinir has been shown to target certain proteins in bacteria, but it is unclear how this contributes to its effectiveness.

When to interrupt dosage

The proposed dose of Cefdinir is hinged on the determined sickness, including Communicable Diseases, Bronchitis and Haemophilus parainfluenzae. The measure of dosage is contingent upon the management methodology (e.g. Capsule or Capsule - Oral) delineated in the accompanying table.

Condition

Dosage

Administration

Bronchitis

300.0 mg, , 125.0 mg/mL, 250.0 mg/mL